Arctic Leaf
A lesser-known indica-leaning strain whose lineage and chemistry are poorly documented outside breeder marketing copy.
Arctic Leaf is one of those names that pops up in seed catalogs and dispensary menus with confident-sounding descriptions, but there is essentially no independent data on it. No peer-reviewed chemistry, no verified lineage records, no clinical anything. What follows is what's reasonably knowable about strains in this general category, combined with honest flags about what is folklore or marketing. If a budtender tells you Arctic Leaf will do something specific to your sleep or anxiety, they are guessing.
Overview
Arctic Leaf is a strain name that appears in some seed bank listings and dispensary menus, typically marketed as a cold-hardy, indica-leaning hybrid suitable for outdoor growers in northern climates. Unlike strains with well-documented histories (e.g., OG Kush or Northern Lights), Arctic Leaf has no published chemotype analyses, no registered breeder of record that we can verify, and no consistent description across vendors No data.
That doesn't mean it isn't a real plant somebody is growing. It means there is no reliable shared definition of what 'Arctic Leaf' is. Two packs from two vendors could be genetically unrelated.
Chemistry: cannabinoids and terpenes
No peer-reviewed chemotype data exists for Arctic Leaf No data. Vendor pages sometimes list THC in the 15–20% range and negligible CBD, but these numbers are not tied to certificates of analysis we can verify.
For context, cannabis flower THC content has risen substantially over recent decades; a long-running analysis of US DEA seizure data found average THC content rose from roughly 4% in 1995 to over 12% by 2014, with modern dispensary flower frequently testing higher still [1] Strong evidence. Without a lab report on a specific Arctic Leaf batch, assume the cannabinoid content is whatever the COA on the jar says — not what the strain name implies Strong evidence.
On terpenes: the common claim that a strain has a single 'dominant terpene' which determines its effects is oversold. Research shows terpene profiles vary widely between batches of the same named strain, and chemovar (chemistry) is a better predictor than name [2][3] Strong evidence. Claims that Arctic Leaf is 'myrcene-dominant and therefore sedating' are folklore unless backed by a specific COA Anecdote.
Reported effects
Vendor and forum descriptions of Arctic Leaf typically claim relaxing, body-heavy, sleep-friendly effects — the standard 'indica' script. There are no controlled studies of this strain's effects on humans No data.
More broadly, the idea that the indica/sativa label predicts effects is not supported by chemistry. A 2022 analysis of nearly 90,000 cannabis samples found that indica/sativa labeling does not reliably correspond to distinct chemical profiles [3] Strong evidence. Effects come from the interaction of cannabinoids, terpenes, dose, route, setting, and individual biology — not from a name on a jar.
If you try Arctic Leaf and find it sedating, that's a real personal observation. It is not evidence that the next jar labeled Arctic Leaf will do the same thing.
Lineage
The lineage of Arctic Leaf is disputed and undocumented Disputed. Some listings imply parentage from northern-adapted classics in the Northern Lights or early auto-flowering family, but we have not found a breeder publication, patent filing, or peer-reviewed genetic analysis that establishes a verified pedigree.
This is common in the cannabis space. Strain names are not regulated trademarks of specific genetics. A 2015 review and subsequent genomic studies have shown that strain names frequently fail to match underlying genetics — different samples sold under the same name can be genetically distant, and samples sold under different names can be near-identical [4] Strong evidence. Treat any lineage claim about Arctic Leaf as marketing copy unless a breeder produces verifiable records.
Cultivation basics
Vendors typically describe Arctic Leaf as a relatively short, bushy plant with a quoted flowering window around 8–9 weeks indoors and reasonable cold tolerance outdoors. These are vendor claims, not independently verified Weak / limited.
General principles that apply regardless of strain name:
- Photoperiod indicas commonly finish in 7–10 weeks of 12/12 flowering indoors.
- Yield is driven more by light intensity (PPFD), VPD, nutrition, and training than by strain identity within a normal range.
- 'Cold-hardy' marketing usually means the plant tolerates cooler night temperatures late in flower; it does not mean it survives frost.
If you're choosing genetics for a specific climate, prioritize a breeder with a documented selection history over a name like 'Arctic' anything.
Marketing vs. reality
What's marketing:
- 'Indica-dominant, so it'll put you to sleep.' The indica label is not a reliable predictor of effects [3] Strong evidence.
- 'Dominant terpene is myrcene, which is sedating above 0.5%.' The 0.5% myrcene sedation threshold is a widely repeated claim with no primary source behind it — it is folklore No data.
- 'Lineage traces back to original Afghani landrace.' Possibly true, unverifiable, and would not change the effects of the specific jar in front of you Disputed.
What's real:
- The COA on your specific package, if one exists, tells you the cannabinoid (and sometimes terpene) content of that batch.
- Your own response to a measured dose, recorded honestly, is more useful than any strain description.
- Strain names are branding. Chemistry, dose, and set/setting do the actual work.
Sources
- Peer-reviewed ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in Cannabis Potency Over the Last 2 Decades (1995–2014): Analysis of Current Data in the United States. Biological Psychiatry. 2016;79(7):613–619.
- Peer-reviewed Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology. 2011;163(7):1344–1364.
- Peer-reviewed Smith CJ, Vergara D, Keegan B, Jikomes N. The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE. 2022;17(5):e0267498.
- Peer-reviewed Sawler J, Stout JM, Gardner KM, Hudson D, Vidmar J, Butler L, Page JE, Myles S. The Genetic Structure of Marijuana and Hemp. PLOS ONE. 2015;10(8):e0133292.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...